Compounds, compositions and methods of using same for modulating uric acid levels

Details for Australian Patent Application No. 2009289646 (hide)

Owner Ardea Biosciences, Inc.

Inventors Gunic, Esmir; Girardet, Jean-Luc; Paisner, David A.

Agent Shelston IP

Pub. Number AU-B-2009289646

PCT Pub. Number WO2010/028189

Priority 61/094,388 04.09.08 US; 61/180,110 20.05.09 US

Filing date 3 September 2009

Wipo publication date 11 March 2010

Acceptance publication date 5 July 2012

International Classifications

C07D 233/42 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/44 - Non-condensed pyridines

A61P 3/00 Drugs for disorders of the metabolism

C07D 233/30 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Event Publications

24 March 2011 PCT application entered the National Phase

  PCT publication WO2010/028189 Priority application(s): WO2010/028189

5 July 2012 Application Accepted

  Published as AU-B-2009289646

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009289647-Compounds, compositions and methods of using same for modulating uric acid levels

2009289644-Methods and compositions for the treatment of cancer